Eviti Connect study showed an increase in clinical uptake of practice-changing data San Antonio, TX – December 11, 2019 –...
Landmark FDA clearance of whole exome sequencing in vitro diagnostic (IVD) test reporting overall tumor mutation burden (TMB) by sequencing...
Collaborating to Improve Quality of Cancer Care Pittsburgh, PA & Culver City, CA – October 23, 2019 – NantHealth,...
Further Enhancing NaviNet’s Ability to Tackle Payer-Provider Communication Challenges June 20, 2018 03:24 PM Eastern Daylight Time LOS ANGELES-NantHealth, Inc....
Platinum sponsor NantHealth will showcase GPS Cancer® and precision medicine solutions for oncology at booth #314 Culver City, California and...
Announces a Record 25 Letters of Authorization to Proceed with Clinical Trials Covering 12 Novel Biological Molecules in 20 Tumor...
Major commercial insurer renews contract of NaviNet and adds NantHealth’s Document Exchange solution to their rolodex CULVER CITY, Calif. – August...
CULVER CITY, Calif.--Mar. 10, 2017-- NantHealth, Inc. (NASDAQ-GS: NH),
Patrick Soon-Shiong, MD, CEO and founder of NantHealth, has been awarded the Intelligent Health Association (IHA) Special Recognition Award. The...
Cancer Treatment Centers of America® Partners with Allscripts and NantHealth
Powerful new suite of payer-sponsored claims applications that lower administrative costs, enhance operating efficiency and eliminate manual workflows for payers...
